You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cMET, INC280, rosuvastatin, digoxin

Showing 1 - 25 of 725
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

cMET-dysregulated Advanced Solid Tumors Trial in Worldwide (INC280, digoxin, rosuvastatin)

Completed
  • cMET-dysregulated Advanced Solid Tumors
  • Atlanta, Georgia
  • +14 more
Dec 8, 2020

Healthy Trial in Salt Lake City (LY3537982, Digoxin, Rosuvastatin)

Not yet recruiting
  • Healthy
  • Salt Lake City, Utah
    ICON Early Clinical & Bioanalytical Solutions
Oct 27, 2023

Healthy Trial in Cypress, South Miami, San Antonio (Imlunestrant, Repaglinide, Omeprazole)

Completed
  • Healthy
  • Cypress, California
  • +2 more
Nov 23, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

NSCLC Trial in Worldwide (INC280 (capmatinib))

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • INC280 (capmatinib)
  • Long Beach, California
  • +95 more
Dec 29, 2022

Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • Houston, Texas
  • +12 more
Jan 31, 2022

Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

Recruiting
  • Advanced Solid Tumors Which Are cMET-dependent
  • Boston, Massachusetts
  • +12 more
Jan 27, 2023

cMET Dysegulation Advanced Solid Tumors Trial in Worldwide (INC280)

Completed
  • cMET Dysegulation Advanced Solid Tumors
  • Indianapolis, Indiana
  • +16 more
Dec 16, 2020

cMET-dysregulated Advanced Solid Tumors Trial in Worldwide (INC280, Midazolam, Caffeine)

Completed
  • cMET-dysregulated Advanced Solid Tumors
  • Atlanta, Georgia
  • +11 more
Dec 8, 2020

Healthy Participants Trial in Salt Lake City (DC-806, Midazolam, Repaglinide)

Not yet recruiting
  • Healthy Participants
  • Salt Lake City, Utah
    ICON Phase 1 Clinic
Oct 16, 2023

Hepatic Impairment Trial in United States (INC280)

Completed
  • Hepatic Impairment
  • Miami, Florida
  • +4 more
Dec 8, 2020

Healthy Volunteers Trial in Austin (Fedratinib, Digoxin, Rosuvastatin)

Completed
  • Healthy Volunteers
  • Austin, Texas
    PPD Phase 1 Clinic
May 20, 2020

Prostate Cancer Trial in Chisinau (enzalutamide, enzalutamide Placebo, digoxin)

Completed
  • Prostate Cancer
  • Chisinau, Moldova, Republic of
    Site MD37301
Jan 14, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Canton, Ohio
    Gabrail Cancer Research Center
Apr 25, 2023

Healthy Volunteers Trial in Beijing (GP681, Rosuvastatin, Digoxin)

Recruiting
  • Healthy Volunteers
  • Beijing, China
    China-Japan Friendship Hospital
Mar 28, 2023

NSCLC Trial in Worldwide (INC280 single agent, erlotinib)

Terminated
  • Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +31 more
Feb 20, 2020

Healthy Trial (ABBV-CLS-7262)

Not yet recruiting
  • Healthy
  • (no location specified)
Mar 8, 2023

Drug Drug Interaction Trial in Guangzhou (Digoxin, Rosuvastatin, ZSP1273)

Recruiting
  • Drug Drug Interaction
  • Guangzhou, China
    The First Affiliated Hospital of Guangzhou University of Chinese
Jul 13, 2023

Healthy Male Subjects Trial (Savolitinib, Digoxin, Metformin Hydrochloride)

Not yet recruiting
  • Healthy Male Subjects
  • (no location specified)
Mar 3, 2023

Chronic Hepatitis B Trial (HRS5091 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)

Completed
  • Chronic Hepatitis B
  • HRS5091 Tablets
  • +6 more
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Dec 22, 2022

Healthy Volunteers Trial (CC-92480, Rifampin, Itraconazole)

Recruiting
  • Healthy Volunteers
  • Dallas, Texas
    Covance Clinical Research Unit - Dallas
Oct 25, 2022

Healthy Male Trial in Shanghai (D-1553)

Active, not recruiting
  • Healthy Male
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
Oct 23, 2023

NSCLC Trial in Jinan (DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin))

Recruiting
  • Non-small Cell Lung Cancer
  • DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin)
  • Jinan, Shandong, China
    Shandong Cancer Hospital (Shandong Provincial Institute of Cance
Jun 22, 2023

Healthy Participants Trial in Brooklyn (AZD5462, Midazolam, Rosuvastatin)

Completed
  • Healthy Participants
  • Brooklyn, Maryland
    Research Site
Oct 10, 2022

Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

Completed
Has Results
  • Malignant Non-small Cell Neoplasm of Lung Stage IV
  • Capmatinib (INC280)
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 11, 2022